Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis

BACKGROUND: Alzheimer’s disease (AD) pathology begins several years before the clinical onset. The long preclinical phase is composed of three stages according to the 2011National Institute on Aging and Alzheimer’s Association (NIA-AA) criteria, followed by mild cognitive impairment (MCI), a feature...

Descripción completa

Detalles Bibliográficos
Autores principales: Parnetti, Lucilla, Chipi, Elena, Salvadori, Nicola, D’Andrea, Katia, Eusebi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334406/
https://www.ncbi.nlm.nih.gov/pubmed/30646955
http://dx.doi.org/10.1186/s13195-018-0459-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334406/
https://www.ncbi.nlm.nih.gov/pubmed/30646955
http://dx.doi.org/10.1186/s13195-018-0459-7

Ejemplares similares